Exelixis Inc. buy Royal Bank of Canada
Start price
13.12.23
/
50%
€21.38
Target price
13.12.24
€24.09
Performance (%)
8.79%
Price
27.09.24
€23.26
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 8.79%. This prediction currently runs until 13.12.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Exelixis Inc. | -3.245% | -3.245% |
iShares Core DAX® | 3.523% | 3.763% |
iShares Nasdaq 100 | 1.026% | 2.380% |
iShares Nikkei 225® | -0.063% | 0.000% |
iShares S&P 500 | 0.557% | 2.222% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $26.00 price target on the stock.
Ratings data for EXEL provided by MarketBeat